503b pharmacy semaglutide The FDA has proposed to bar outsourcing facilities from bulk compounding and tirzepatide. The shortage-list pathway already closed in 2024 and 2025; this proposal would remove the remaining bulks-list route 503B Compounding Pharmacy | Clinical

New drugs for the treatment of obesity: do we need approaches to preserve muscle mass

Pancreatic and Gallbladder Conditions People with a history of acute pancreatitis or gallbladder disease may face heightened risks when using GLP-1 medications

This risk appears to increase with treatment duration beyond 1.5 years

Should you experience any elevated heart rate or blood pressure when taking steroids we strongly recommend that you stop usage and see a doctor immediately

This article will discuss the different reasons for sweating in sleep and ways to stop it so you can get better sleep

However, severe upper abdominal pain that radiates to the back, especially if accompanied by nausea, vomiting, and fever